Home › Rheumatoid Arthritis › NCT04748809
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
An Evaluator-blinded Randomized Controlled Trial Study of the Effect of Anti-inflammatory Diet in Subjects With Rheumatoid Arthritis.
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with low or moderate disease activity (defined as Clinical Disease Activity Index ≤ 22) and without changes in disease activity or therapy during the previous 3 months, who are interested in dietary intervention, and are able to provide consent and attend to follow up visits. Exclusion Criteria: * Pregnancy or lactating. Patients that will become pregnant during the study will be remove from the study. * Food allergies * Subjects with significant other comorbidities and /or medication use which in physician's clinical judgment might difficult the interpretation of the results
About the study
In a previous exploratory study, the investigators observed an effect on disease activity outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and circulating metabolites. The current study will determine whether or not the addition of anti-inflammatory diet improves the clinical outcomes in participants with rheumatoid arthritis, and the role of microbiome and circulating metabolites.
What is being tested
- Diet 1 (other)
- Diet 2 (other)
Sponsor: University of California, San Diego · Participants: 124 · Started: Nov 1, 2020
Contact the study team
- Monica Guma, MD, PhD · Phone: 8588226523
Official record on ClinicalTrials.gov — NCT04748809
Locations in the U.S.
| California | UCSD, La Jolla |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.